Round window application of D-methionine provides complete cisplatin otoprotection

Otolaryngology - Head and Neck Surgery

Volumn 126, Issue 6, 2002, Pages 683-689

  Korver, Kurtis D ^a,b   Rybak, Leonard P ^a,b,c   Whitworth, Craig ^a,b   Campbell, Kathleen M ^a,b  

^a Southern Illinois University ^*

^b SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Section of Colorectal Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; METHIONINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHINCHILLA; COCHLEA FENESTRA; CONTROLLED STUDY; CORTI ORGAN; EAR PROTECTION; EVOKED BRAIN STEM RESPONSE; HAIR CELL; HEARING LOSS; NONHUMAN; OTOTOXICITY; ANIMAL; AUDIOMETRY; AUDITORY THRESHOLD; CHEMICALLY INDUCED DISORDER; COCHLEA; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECT; DRUG INTERACTION; FEMALE; MALE; PATHOLOGY; PERCEPTION DEAFNESS; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANIMALS; AUDIOMETRY; AUDITORY THRESHOLD; CHINCHILLA; CISPLATIN; COCHLEA; DISEASE MODELS, ANIMAL; DRUG INTERACTIONS; FEMALE; HEARING LOSS, SENSORINEURAL; MALE; METHIONINE; REFERENCE VALUES; ROUND WINDOW; SENSITIVITY AND SPECIFICITY;

EID: 0036598487     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhn.2002.125299     Document Type: Article

References (22)

1. Gandara DR, Wiebe VJ, Perez EA, et al. Cisplatin rescue therapy: experience with sodium thiosulfate, WR2721 and diethyldithiocarbamate. Crit Rev Oncol Hematol 1990;10:353-65.
2. Laurell G, Bugger-Sjöbäck D. Dose-dependent inner ear changes after IV administration of cisplatin. J Otolaryngol 1991;20:3:158-67.
3. Aamdal S, Fodstad O, Pihl A. Some procedures to reduce cis-platinum toxicity reduce antitumor activity. Cancer Treat Rev 1987;14:389-95.
4. Blakely B, Gupta A, Myers S, et al. Risk factors for ototoxicity due to cisplatin. Arch Otolaryngol Head Neck Surg 1994;120:541-6.
5. Freilich RV, Kraus DH, Budnick AS, et al. Hearing loss in children with brain tumors treated with cisplatin and carboplatin-based high-dose chemotherapy with autologous bone marrow rescue. Med Pediatr Oncol 1996;26: 95-100.
6. Bert A, Spitzer J, Garvin J, et al. Ototoxic impact of cisplatin in pediatric oncology patients. Laryngoscope 1999;109:1806-14.
7. Jones M, Bassenger M. Thiolan thioether suppression of cisplatinum-induced nephrotoxicity in rats bearing the Walker 256 carcinosarcoma. Anticancer Res 1989;9:1937-42.
8. Campbell KM, Rybak LP, Meech, RP et al. d-Methionine provides complete protection from cisplatin ototoxicity in the rat. Hear Res 1996;102:90-8.
9. Church MW, Kalternbach VA, Blakley BW, et al. The comparative effects of sodium thiosulfate, diethyldithiocarbamate, fosfomycin and WR-2721 on ameliorating cisplatin-induced ototoxicity. Hear Res 1995;861:195-203.
10. Stegink L, Schmitt J, Meyer P, et al. Effect of diets fortified with Dl-methionine levels in young infants. J Pediatr 1971;79:648-56.
11. Printen K, Brummel M, Cho, et al. Utilization of D-methionine during total parenteral nutrition in postsurgical patients. Am J Clin Nutr 1979;32:1200-5.
12. Ivanov A, Christodoulou J, Parkinson J, et al. Cisplatin binding sites on human albumin. J Biol Chem 1998;273:24:14721-30.
13. Hoshiya Y, Kubota T, Matsuzaki S, et al. Methionine starvation modulates the efficacy of cisplatin on human breast cancer in nude mice. Anticancer Res 1996;16:6515-8.
14. Janning M, Whitworth C, Rybak L. Experimental model of cisplatin ototoxicity in chinchillas. Otolaryngol Head Neck Surg 1998;119:574-80.
15. Goycoolea MV, Lundman E. Round window membrane: structure function and permeability: a review. Microsc Res Techn 1997;36:201-11.
16. Gillette-Cloven N, Re A, Campbell K, et al. Evaluation of D-methionine as a cytoprotectant in cisplatin treatment of an animal model for ovarian cancer. Anticancer Res 2000;20:4205-9.
17. Melvick J, Pettersen E. Reduction of cis-dichlorodiammine platinum-induced cell inactivation by methionine. Inorg Chim Acta 1987;137:115-8.
18. Reser DH, Rho MB, Dewan D, et al. l- And d- methionine provide equivalent long term protection against CDDP-induced ototoxicity in vivo, with partial in vitro and in vivo retention of antineoplastic activity. Neurotoxicology 1999;20:731-48.
19. Li G, Frenz DA, Brahmblatt S, et al. Round window membrane delivery of l-methionine provides protection from cisplatin ototoxicity without compromising chemotherapeutic efficacy. Neurotoxicology 2001;22:163-76.
20. Mineara K, Sasijima T, Sasajima H, et al. Inhibition of methionine uptake by cis-diamminedichloroplatinum II in experimental brain tumors. Int J Cancer 1996;67:681-3.
21. Deegan P, Pratt I, Ryan M. The nephrotoxicity, cytotoxicity and renal handling of a cisplatin-methionine complex in male Wistar rats. Toxicology 1994;89:1-14.
22. Saito T, Yamada T, Manabe Y, et al. Cisplatin metabolites and their toxicities on isolated cochlear outer hair cells in vitro. Acta Otolaryngol 1996;116:561-5.